A Study to Investigate the Antimicrobial Activity of 2 Test Toothpastes
- Conditions
- Dental Plaque
- Interventions
- Other: Test zinc-IPMP toothpasteOther: Test zinc non- IPMP toothpasteOther: SLS negative controlOther: Positive controlOther: non-SLS negative control
- Registration Number
- NCT02856880
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The aim of this exploratory study is to assess the ability of two test toothpastes containing 0.6% w/w zinc chloride stabilised with sodium citrate in a sodium lauryl sulfate (SLS)-containing base to reduce glycolytic metabolism and viability of de novo plaque bacteria using the plaque glycolysis regrowth model (PGRM).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
- Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
- Good general and mental health with, in the opinion of the investigator or medically qualified designee no clinically significant and relevant abnormalities in medical history or upon oral examination.
- Plaque sample acidogenicity in the pH range 5.0 to 5.7 at Visit.
- Women who are known to be pregnant or who are intending to become pregnant over the duration of the study.
- Women who are breast-feeding.
- Currently taking antibiotics or have taken antibiotics within 2 weeks of plaque assessment (Visit 2). A participant with any medical history that may prevent them from participating in the study until study conclusion (such as diabetes).
- Any sign of grossly carious lesions (active), moderate or severe periodontal conditions, or severe tooth wear.
- Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
- Current smokers, or smokers who have quit within 6 months of screening, or participants currently using smokeless forms of tobacco, e.g. Gutkha, Pan containing tobacco, Pan Masala.
- Current active caries or periodontitis that may compromise, in the opinion of the investigator, study outcomes or the health of the subject.
- Restorations in a poor state of repair that may, in the opinion of the investigator, compromise study outcomes or the health of the participant.
- Partial dentures or orthodontic appliances that may, in the opinion of the investigator, compromise study outcomes or the health of the participant.
- Recent history (within the last year) of alcohol or other substance abuse.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Test zinc-IPMP toothpaste Test zinc-IPMP toothpaste Rinse with preprepared slurry of toothpaste in 10 milliliter (mL) water for 60 seconds(s) followed by rinse with 10mL water Test zinc non- IPMP toothpaste Test zinc non- IPMP toothpaste Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water SLS Negative Control SLS negative control Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water Positive control Toothpaste Positive control Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water non-SLS negative control non-SLS negative control Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water
- Primary Outcome Measures
Name Time Method Area Under the Curve for Glycolysis (AUCgly(0-90)) of Test Zinc-IPMP and Non-SLS Negative Control Baseline up to 90 minutes (min) AUCgly(0-90) of Test zinc-IPMP and non-SLS negative control was calculated using trapezoidal method.
- Secondary Outcome Measures
Name Time Method AUCgly(0-90) for Test Zinc-IPMP, Test Zinc Non-IPMP, Positive Control, Non-SLS Negative Control and SLS Negative Control Baseline up to 90 min AUCgly(0-90) for test zinc-IPMP, test zinc non-IPMP, positive control, non-SLS negative control and SLS negative control was calculated using trapezoidal method.
AUCregrowth(0-90) for Test Zinc-IPMP, Test Zinc Non-IPMP, Positive Control, Non-SLS Negative Control and SLS Negative Control Baseline up to 90 min AUCregrowth(0-90) for test zinc-IPMP, test zinc non-IPMP, positive control, non-SLS negative control and SLS negative control was calculated using trapezoidal method.
AUClive:Dead(0-90) for Test Zinc-IPMP, Test Zinc Non-IPMP, Positive Control, Non-SLS Negative Control and SLS Negative Control Baseline up to 90 min AUClive:dead(0-90) for test zinc-IPMP, test zinc non-IPMP, positive control, non-SLS negative control and SLS negative control was calculated using trapezoidal method.
Trial Locations
- Locations (1)
GSK Investigational Site
🇬🇧Manchester, United Kingdom